Factor VIII - von Willebrand Factor comment watch save

  • TRADE NAMES: Alphanate (Grifols); Haemate (CSL Behring); Opivate (BPL); Vonvendi
  • INDICATIONS: Control and prevention of bleeding in patients with hemophilia A; surgical procedures in patients with von Willebrand disease in whom desmopressin is either ineffective or contraindicated
  • CLASS: Antihemorrhagic, Coagulation factor VIII
  • HALF-LIFE: 12.4 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    None known

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top